NICE Approved Acomplia

July 18, 2008

The National Institute for Health and Clinical Excellence (NICE) has issued new guidance recommending use of Acomplia (rimonabant) in England and Wales, within its licensed indications, as an adjunct to diet and exercise for adults who are obese or overweight and who have had an inadequate response to, are intolerant of or are contraindicated to other anti-obesity agents that have previously been reviewed by NICE